Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in RA and Spondyloarthritis Patients, Treated With TNFalpha-inhibitors in Combination With Methotrexate or Methotrexate or TNFalpha-inhibitors Alone - a Prospective Study
Observational
Observational Model: Cohort, Time Perspective: Prospective
To examine the association between inflammatory disease activity and endothelial function in RA and spondyloarthritis patients treated with methotrexate and TNFalpha-inhibitor in combination or methotrexate or TNFalpha-inhibitor alone
Baseline (before treatment starts), 6 weeks and 6 months after starting treatment
No
Knut Mikkelsen, MD
Study Chair
Lillehammer Hospital for Rheumatic Diseases
Norway: Data Protection Authority
S-07377b
NCT00902005
April 2008
June 2012
Name | Location |
---|